Cancer - Preclinical Research – Therapeutics Biotect Services, Inc. advances preclinical research of vaccines and cancer therapeutics, with a particular focus on brain cancer, expressly glioblastoma multiforme (GBM). We specialize in 2D and 3D tissue culture-based assays to measure and monitor product efficacy. Under development is a cerebral organoid GBM model that mimics the tumor microenvironment and increases predictability of drug effectiveness over traditional in-vitro and in-vivo models prior to clinical studies. Our mission is to facilitate and improve preclinical development of cancer therapies, reducing time from discovery to the clinic. Contact us today to talk about what we can do for you!